C WorldWide Group Holding A S lifted its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 11.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,172,238 shares of the medical research company’s stock after buying an additional 222,189 shares during the period. Thermo Fisher Scientific comprises 5.8% of C WorldWide Group Holding A S’s portfolio, making the stock its 7th largest holding. C WorldWide Group Holding A S owned about 0.56% of Thermo Fisher Scientific worth $378,990,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of TMO. BlackRock Inc. lifted its stake in shares of Thermo Fisher Scientific by 2,692.1% in the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock worth $3,531,095,000 after buying an additional 22,165,530 shares in the last quarter. Harbour Capital Advisors LLC lifted its stake in shares of Thermo Fisher Scientific by 18,197.5% in the second quarter. Harbour Capital Advisors LLC now owns 1,201,051 shares of the medical research company’s stock worth $6,884,000 after buying an additional 1,194,487 shares in the last quarter. Veritas Asset Management LLP bought a new position in shares of Thermo Fisher Scientific in the first quarter worth approximately $175,795,000. Vanguard Group Inc. lifted its stake in shares of Thermo Fisher Scientific by 2.7% in the first quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock worth $3,989,193,000 after buying an additional 695,079 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its stake in shares of Thermo Fisher Scientific by 68.8% in the first quarter. Renaissance Technologies LLC now owns 1,373,044 shares of the medical research company’s stock worth $210,900,000 after buying an additional 559,400 shares in the last quarter. Hedge funds and other institutional investors own 83.36% of the company’s stock.

In other Thermo Fisher Scientific news, Director C Martin Harris sold 360 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total transaction of $65,149.20. Following the completion of the sale, the director now directly owns 5,312 shares in the company, valued at approximately $961,312.64. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jim P. Manzi sold 11,318 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the sale, the director now owns 38,757 shares of the company’s stock, valued at $6,702,635.58. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,738 shares of company stock valued at $4,021,512. Company insiders own 0.49% of the company’s stock.

Several research analysts have recently issued reports on the stock. Deutsche Bank AG set a $200.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Saturday, June 10th. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday. Wells Fargo & Company restated an “outperform” rating and set a $200.00 price objective (up previously from $195.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 13th. Bank of America Corporation restated a “buy” rating and set a $210.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Finally, Cleveland Research upgraded shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Two research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $193.56.

Shares of Thermo Fisher Scientific Inc (TMO) opened at 188.60 on Thursday. The stock has a market capitalization of $73.58 billion, a PE ratio of 32.86 and a beta of 1.05. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $194.30. The firm’s 50-day moving average is $181.07 and its 200-day moving average is $171.15.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same period in the previous year, the business posted $2.03 EPS. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. On average, analysts expect that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.32%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s payout ratio is 10.45%.

WARNING: This article was reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.dailypolitical.com/2017/09/21/thermo-fisher-scientific-inc-tmo-is-c-worldwide-group-holding-a-ss-7th-largest-position.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.